Compliance review: Sun Pharma’s Halol plant gets 8 USFDA...

Dununu.com Dununu

Gesponsert

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

RSS Feed Business

Posted

95

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.

Read Full Article

Please log in to like, share and comment!

NOC hikes Petrol and diesel prices

KATHMANDU: Nepal Oil Corporation has revised the retail prices of petroleum products across the...

Von 0 1

'Wedding of liberal royalty': Alex Soros marries Hillary Clinton's ex-aide Huma Abedin

Von 0 6

Aamir on reason behind naming his children Junaid, Ira, Azad

Aamir Khan recently addressed the reason behind his children's Islamic-rooted names, Junaid, Ira,...

Von 0 8

Trade Tower Limited IPO allotment finalized

KATHMANDU: The IPO allotment of Trade Tower Limited was completed in Kathmandu today. From Jestha...

Von 0 9

Landing gear snag: Air India Delhi-Vadodara flight makes emergency landing

Von 0 9